November 19th, 2026Iron Deficiency in Heart Failure Is a Workflow Problem, Faculty SayFaculty say heart failure patients miss iron deficiency care when no one owns it; pharmacist-led workflows may help close the gap.Read more
November 19th, 2026FDA Approves First siRNA Therapy for AChR-Positive Myasthenia GravisThe FDA approved cemdisiran (Livsayis; Regeneron), a subcutaneous siRNA dosed every 3 months, for AChR-positive generalized myasthenia gravis.Read more
November 19th, 2026Most Patients With Psoriasis Screened Positive for PsA at One Dermatology ClinicIn a single-clinic study, 61.5% of patients with psoriasis screened positive for psoriatic arthritis using a validated questionnaire.Read more
November 19th, 2026Obesity Care Ownership Shifts to Specialties That Win CoveragePharmacy teams can shorten the time of Medicare GLP-1 Bridge approvals, but 2027 approval windows may leave patients without titration check-ins.Read more
November 19th, 2026New Employer Guide Maps Diabetes Prevention, Care ResourcesAn employer coalition's new guide outlines how workplaces can prevent and manage diabetes, from benefit design to accommodations.Read more
November 18th, 2026Low CRC Incidence Found After Endoscopic Mucosal ResectionCRC diagnoses after endoscopic mucosal resection (EMR) were uncommon in a real-world cohort, though racial and ethnic differences remain unclear.Read more
November 18th, 2026FDA Approves Obinutuzumab as First Therapy for Membranous NephropathyObinutuzumab (Gazyva) led to complete remission of proteinuria in more patients than tacrolimus did, according to the FDA.Read more
November 18th, 2026Complicated UTI Care Strained by Unclear Goals, Access GapsInfectious disease and urology clinicians described unclear treatment goals, infusion limits, and access barriers for newer UTI agents.Read more